Shifa Biomedical
Dr. Foley has over 30 years pharmaceutical industry experience spanning R&D, corporate development and licensing. He served as Head of Business Development and Licensing of pharmaceuticals for Japan and Asia/Pacific regions at Bristol Myers Squibb, SmithKline Beecham and GlaxoSmithKline. He has an extensive longstanding relationships with Japanese and Korean pharmaceutical industry. He was a Former member of Board of Directors of Sosei & Co. in Tokyo. He was responsible for hundreds of millions of dollars worth of transactions in anti-infectives, inflammation, cardiovascular and cancer areas.
Dr. Foley specialties is in business development, asset management strategy, licensing, partnering, R&D collaborations, in the US, Europe and Japan/Asia. He received a Ph.D. in Physiology and Pharmacology from Thomas Jefferson University and a BA in Biology and Chemistry from Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Shifa Biomedical
Shifa Biomedical is a drug discovery company that develops drugs for the treatment of cardiovascular disease.